"This is the end of the matter and we are very happy." That was the reaction of Luca Pani, head of the Italian Medicines Agency, to the news in October that the Italian health minister had halted a government trial of a controversial stem-cell therapy. He is less happy now, and his dissatisfaction should be shared by anyone who cares about the rigorous use of scientific evidence and the nrorection of vulnerable narients.
展开▼